83/100 A · Moderate risk
No major risk flags in the public sources we cover Indicative TraceComp estimate from public sources — an automated indicator, not a credit decision, a completed due-diligence check, or a guarantee. Verify against the official register.

ℹ️ No matches surfaced in the limited public sources we cover (sanctions, screening, insolvency, control). This is an automated indicator — not an exhaustive check, a credit decision, or a guarantee, and absence of a match does not mean none exists. Verify against the official register.

Think this is wrong? This is an automated estimate — request a human review or correction.

TYPHONIX AS

Active Aksjeselskap 📍 Bryne Other professional & technical Active for 17 years

Aksjeselskap · RC 893164472 · Active since 2008

A

Overview

TYPHONIX AS is an aksjeselskap registered in Bryne, Norway, since 2008. The company operates in the other professional & technical sector. Its TraceComp score of 83 (A) indicates solid fundamentals and low apparent risk. With 17 years of operations, the company has an established track record in its market.

Company Information

Registration Number
893164472
Legal Form
Aksjeselskap
Registered
2008-09-29
Address
Bryne

Financial Profile

Latest filed accounts: FY 2024

Revenue (2024) —
Net Income 5,830,199 NOK
Total Assets 20,995,099 NOK
Altman Z 1.76 grey

Multi-year financials & ratios

1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Research Output

Active research organization. 10 publications · 98 citations · h-index 7 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Engineering (96%) · Medicine (4%).

See full research profile — top researchers & publications →

Source: OpenAlex (CC0). Objective publication & citation counts.

Patent Portfolio

Active patent holder. 7 patents · 7 active · 7 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • Profitable: positive net income in FY 2024

Data Sources & Freshness

Data sourced from: bulk register.